Our data suggest that the NOD background could impact lipid metabolism and confer resistance to hyperlipidemia development; however, simultaneous genetic inactivation of both ApoE and LDLR was sufficient to model both severe hyperlipidemia and severe atherosclerosis. The gene discussed is APOE; the disease is hyperlipidemia.